Crystal structure of HIV-1 Tat complexed with human P-TEFb

[20] Processing of X-ray diffraction data collected in oscillation mode

Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse‐Kunstleve, R. W., Jiang, J., Kuszewski, J. J., Nilges, M., Pannu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,723

WebLogo: A Sequence Logo Generator: Figure 1Preprint

Crooks, G. E., Hon, G. C., Chandonia, J., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,480

Controlling the elongation phase of transcription with P-TEFb

Peterlin, B. M., & Price, D. H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.014 · Cited by 1,144

Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 899

Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitors

Pavletich, N. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2640 · Cited by 746

Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitroPreprint

Zhu, Y., Peery, T., Peng, J., Ramanathan, Y., Marshall, N. F., Marshall, T. K., Amendt, B. A., Mathews, M. B., & Price, D. H. (1997) · Genes & Development · doi:10.1101/gad.11.20.2622 · Cited by 700

Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase

Marshall, N. F., Peng, J., Xie, Z., & Price, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27176 · Cited by 662

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004

Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2006) · AIDS · doi:10.1097/01.aids.0000247564.73009.bc · Cited by 627

Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo

Chao, S., & Price, D. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102306200 · Cited by 623

RNA Polymerase II Elongation Control

Zhou, Q., Li, T., & Price, D. H. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052610-095910 · Cited by 590

HIV LatencyPreprint

Siliciano, R. F., & Greene, W. C. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007096 · Cited by 552

Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression

Karn, J., & Stoltzfus, C. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006916 · Cited by 437

The structural biology of HIV-1: mechanistic and therapeutic insights

Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 499

Mediator kinase inhibition further activates super-enhancer-associated genes in AML

Pelish, H. E., Liau, B. B., Nitulescu, I. I., Tangpeerachaikul, A., Poss, Z. C., Silva, D. H. D., Caruso, B., Arefolov, A., Fadeyi, O., Christie, A. L., et al. (2015) · Nature · doi:10.1038/nature14904 · Cited by 406

HIV-1 transcription and latency: an update

Lint, C. M. V., Bouchat, S., & Marcello, A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-67 · Cited by 352

Structure and mechanism of the RNA polymerase II transcription machineryPreprint

Schier, A. C., & Taatjes, D. J. (2020) · Genes & Development · doi:10.1101/gad.335679.119 · Cited by 327

The Control of HIV Transcription: Keeping RNA Polymerase II on Track

Ott, M., Geyer, M., & Zhou, Q. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.11.002 · Cited by 284

Structural insights into the functional diversity of the CDK–cyclin family

Wood, D. J., & Endicott, J. (2018) · Open Biology · doi:10.1098/rsob.180112 · Cited by 272

NMR paves the way for atomic level descriptions of sparsely populated, transiently formed biomolecular conformers

Sekhar, A., & Kay, L. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305688110 · Cited by 252

The Ins and Outs of HIV ‐1 Tat

Debaisieux, S., Rayne, F., Yezid, H., & Beaumelle, B. D. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01286.x · Cited by 267

CDK1 structures reveal conserved and unique features of the essential cell cycle CDK

Brown, N. R., Korolchuk, S., Martin, M. P., Stanley, W. A., Moukhametzianov, R., Noble, M. E. M., & Endicott, J. (2015) · Nature Communications · doi:10.1038/ncomms7769 · Cited by 238

Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation

Itzen, F., Greifenberg, A. K., Bösken, C. A., & Geyer, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku449 · Cited by 245

Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure

Mbonye, U. R., & Karn, J. (2014) · Virology · doi:10.1016/j.virol.2014.02.008 · Cited by 232

CDK9: a signaling hub for transcriptional control

Bacon, C. W., & D’Orso, I. (2018) · Transcription · doi:10.1080/21541264.2018.1523668 · Cited by 206

Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition

Czudnochowski, N., Bösken, C. A., & Geyer, M. (2012) · Nature Communications · doi:10.1038/ncomms1846 · Cited by 191

The Molecular Basis for Human Immunodeficiency Virus Latency

Mbonye, U., & Karn, J. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041646 · Cited by 182

7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription

Peterlin, B. M., Brogie, J. E., & Price, D. H. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.106 · Cited by 181

The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit

Karn, J. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328340ffbb · Cited by 178

P-TEFb: The master regulator of transcription elongation

Fujinaga, K., Huang, F., & Peterlin, B. M. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.006 · Cited by 156

Ready, pause, go: regulation of RNA polymerase II pausing and release by cellular signaling pathways

Liu, X., Kraus, W. L., & Bai, X. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.07.003 · Cited by 163

Tat is a multifunctional viral protein that modulates cellular gene expression and functions

Clark, E. A., Nava, B. C., & Caputi, M. (2017) · Oncotarget · doi:10.18632/oncotarget.15174 · Cited by 132

Curcumin inhibits HIV-1 by promoting Tat protein degradation

Ali, A., & Banerjea, A. C. (2016) · Scientific Reports · doi:10.1038/srep27539 · Cited by 122

The nexus between RNA-binding proteins and their effectors

He, S., Valkov, E., Cheloufi, S., & Murn, J. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00550-0 · Cited by 122

RNA Polymerase II Transcription Elongation Control

Guo, J., & Price, D. H. (2013) · Chemical Reviews · doi:10.1021/cr400105n · Cited by 119

CBFβ Stabilizes HIV Vif to Counteract APOBEC3 at the Expense of RUNX1 Target Gene Expression

Kim, D. Y., Kwon, E., Hartley, P. D., Crosby, D. C., Mann, S., Krogan, N. J., & Gross, J. D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.12.012 · Cited by 119

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

Kryštof, V., Baumli, S., & Fürst, R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800672750 · Cited by 112

The Mechanism of Release of P-TEFb and HEXIM1 from the 7SK snRNP by Viral and Cellular Activators Includes a Conformational Change in 7SK

Krueger, B. J., Varzavand, K., Cooper, J. J., & Price, D. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012335 · Cited by 111

Protein intrinsic disorder as a flexible armor and a weapon of HIV-1

Xue, B., Mizianty, M. J., Kurgan, L., & Uversky, V. N. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0859-3 · Cited by 107

Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms

Karn, J., & Mbonye, U. R. (2011) · Current HIV Research · doi:10.2174/157016211798998736 · Cited by 102

CDK9 keeps RNA polymerase II on track

Egloff, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03878-8 · Cited by 104

HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity

Hategan, A. P., Bianchet, M. A., Steiner, J. P., Karnaukhova, E., Masliah, E., Fields, A., Lee, M., Dickens, A. M., Haughey, N. J., Dimitriadis, E. K., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3379 · Cited by 93

Phosphorylation of CDK9 at Ser175 Enhances HIV Transcription and Is a Marker of Activated P-TEFb in CD4+ T Lymphocytes

Mbonye, U. R., Gokulrangan, G., Datt, M., Dobrowolski, C. N., Cooper, M., Chance, M. R., & Karn, J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003338 · Cited by 95

HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold

Chou, S., Upton, H., Bao, K., Schulze-Gahmen, U., Samelson, A. J., He, N., Nowak, A., Lu, H., Krogan, N. J., Zhou, Q., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216971110 · Cited by 93

Transcription Factors Mediate the Enzymatic Disassembly of Promoter-Bound 7SK snRNP to Locally Recruit P-TEFb for Transcription Elongation

McNamara, R. P., McCann, J. L., Gudipaty, S. A., & D’Orso, I. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.003 · Cited by 90

HIV Genome-Wide Protein Associations: a Review of 30 Years of Research

Li, G., & Clercq, E. D. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00065-15 · Cited by 105

Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat

Mediouni, S., Chinthalapudi, K., Ekka, M. K., Usui, I., Jablonski, J. A., Clementz, M. A., Mousseau, G., Nowak, J., Macherla, V. R., Beverage, J. N., et al. (2019) · mBio · doi:10.1128/mbio.02662-18 · Cited by 84

Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex

Schulze‐Gahmen, U., & Hurley, J. H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806438115 · Cited by 86

Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors

Németh, G., Greff, Z., Sipos, A., Varga, Z., Székely, R., Sebestyén, M., Jászay, Z. M., Béni, S., Nemes, Z., Pirat, J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401742r · Cited by 81

AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation

Lu, H., Li, Z., Xue, Y., Schulze‐Gahmen, U., Johnson, J. R., Krogan, N. J., Alber, T., & Zhou, Q. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318503111 · Cited by 80

The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat

Schulze‐Gahmen, U., Upton, H. E., Birnberg, A., Bao, K., Chou, S., Krogan, N. J., Zhou, Q., & Alber, T. (2013) · eLife · doi:10.7554/elife.00327 · Cited by 79

Architecture and RNA binding of the human negative elongation factor

Vos, S. M., Pöllmann, D., Caizzi, L., Hofmann, K., Rombaut, P., Zimniak, T., Herzog, F., & Cramer, P. (2016) · eLife · doi:10.7554/elife.14981 · Cited by 84

HIV, Tat and dopamine transmission

Gaskill, P. J., Miller, D. R., Gamble‐George, J., Yano, H., & Khoshbouei, H. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.015 · Cited by 78

Genetic variation and function of the HIV-1 Tat protein

Spector, C., Mele, A. R., Wigdahl, B. L., & Nonnemacher, M. R. (2019) · Medical Microbiology and Immunology · doi:10.1007/s00430-019-00583-z · Cited by 82

Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA

Lalonde, M. S., Lobritz, M. A., Ratcliff, A. N., Chamanian, M., Athanassiou, Z., Tyagi, M., Wong, J. Y., Robinson, J. A., Karn, J., Varani, G., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002038 · Cited by 76

Comparative Structural and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 Inhibitors Suggest the Basis for Isotype Selectivity

Hole, A. J., Baumli, S., Shao, H., Shi, S., Huang, S., Pepper, C. J., Fischer, P. M., Wang, S., Endicott, J., & Noble, M. E. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301495v · Cited by 73

Targeting HIV Transcription: The Quest for a Functional Cure

Mousseau, G., Mediouni, S., & Valente, S. T. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_435 · Cited by 75

HIV Control Is Mediated in Part by CD8 + T-Cell Targeting of Specific Epitopes

Pereyra, F., Heckerman, D. E., Carlson, J. M., Kadie, C. M., Soghoian, D. Z., Karel, D., Goldenthal, A. R., Davis, O. B., DeZiel, C. E., Lin, T.-H., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01004-14 · Cited by 72

The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE

Paparidis, N. F. D. S., Durvale, M. D. C., & Canduri, F. (2016) · Molecular BioSystems · doi:10.1039/c6mb00387g · Cited by 72

Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation

Zheng, B., Gold, S. R., Iwanaszko, M., Howard, B. C., Wang, L., & Shilatifard, A. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.032 · Cited by 78

Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation

Mbonye, U. R., Wang, B., Gokulrangan, G., Shi, W., Yang, S., & Karn, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001347 · Cited by 71

RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev–Rev response element complex

Jayaraman, B., Crosby, D. C., Homer, C. M., Ribeiro, I., Mavor, D., & Frankel, A. D. (2014) · eLife · doi:10.7554/elife.04120 · Cited by 74

Extracellular vesicles in virus infection and pathogenesis

McNamara, R. P., & Dittmer, D. P. (2020) · Current Opinion in Virology · doi:10.1016/j.coviro.2020.07.014 · Cited by 69

Structure of a low-population binding intermediate in protein-RNA recognition

Borkar, A. N., Bardaro, M. F., Camilloni, C., Aprile, F. A., Varani, G., & Vendruscolo, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521349113 · Cited by 66

The CDK9 C-helix Exhibits Conformational Plasticity That May Explain the Selectivity of CAN508

Baumli, S., Hole, A. J., Noble, M. E. M., & Endicott, J. (2012) · ACS Chemical Biology · doi:10.1021/cb2004516 · Cited by 63

Lost in Transcription: Molecular Mechanisms that Control HIV Latency

Taube, R., & Peterlin, B. M. (2013) · Viruses · doi:10.3390/v5030902 · Cited by 63

Structural insight into the mechanism of stabilization of the 7SK small nuclear RNA by LARP7

Uchikawa, E., Natchiar, K., Han, X. Y., Proux, F., Roblin, P., Zhang, E., Durand, A., Klaholz, B. P., & Dock‐Brégeon, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv173 · Cited by 60

Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4

Gu, J., Babayeva, N. D., Suwa, Y., Baranovskiy, A. G., Price, D. H., & Tahirov, T. H. (2014) · Cell Cycle · doi:10.4161/cc.28756 · Cited by 58

Tits and bits of HIV Tat protein

Johri, M. K., Mishra, R., Chhatbar, C., Unni, S. K., & Singh, S. K. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.546339 · Cited by 64

Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex

Schulze‐Gahmen, U., Echeverria, I., Stjepanović, G., Bai, Y., Lu, H., Schneidman‐Duhovny, D., Doudna, J. A., Zhou, Q., Šali, A., & Hurley, J. H. (2016) · eLife · doi:10.7554/elife.15910 · Cited by 60

Crosstalk between histone modifications indicates that inhibition of arginine methyltransferase CARM1 activity reverses HIV latency

Zhang, Z., Nikolai, B. C., Gates, L. A., Jung, S. Y., Siwak, E. B., He, B., Rice, A. P., O’Malley, B. W., & Feng, Q. F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx550 · Cited by 58

Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription

Faust, T. B., Binning, J. M., Gross, J. D., & Frankel, A. D. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041654 · Cited by 64

Live-cell imaging reveals the spatiotemporal organization of endogenous RNA polymerase II phosphorylation at a single gene

Forero-Quintero, L. S., Raymond, W., Handa, T., Saxton, M. N., Morisaki, T., Kimurâ, H., Bertrand, É., Munsky, B. E., & Stasevich, T. J. (2021) · Nature Communications · doi:10.1038/s41467-021-23417-0 · Cited by 60

AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter

Schulze‐Gahmen, U., Lu, H., Zhou, Q., & Alber, T. (2014) · eLife · doi:10.7554/elife.02375 · Cited by 58

An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb

Shortridge, M. D., Wille, P. T., Jones, A. N., Davidson, A., Bogdanović, J., Arts, E. J., Karn, J., Robinson, J. A., & Varani, G. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1197 · Cited by 61

Transition Step during Assembly of HIV Tat:P-TEFb Transcription Complexes and Transfer to TAR RNA

D’Orso, I., Jang, G. Μ., Pastuszak, A. W., Faust, T. B., Quezada, E. M., Booth, D. S., & Frankel, A. D. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00206-12 · Cited by 54

Functional Segregation of Overlapping Genes in HIV

Fernandes, J. D., Faust, T. B., Strauli, N. B., Smith, C. L., Crosby, D. C., Nakamura, R. L., Hernandez, R. D., & Frankel, A. D. (2016) · Cell · doi:10.1016/j.cell.2016.11.031 · Cited by 54

Viral–Host Interactions That Control HIV-1 Transcriptional Elongation

Lu, H., Li, Z., Xue, Y., & Zhou, Q. (2013) · Chemical Reviews · doi:10.1021/cr400120z · Cited by 56

HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein

Hategan, A. P., Masliah, E., & Nath, A. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00736-z · Cited by 52

Reconstitution of a functional 7SK snRNP

Brogie, J. E., & Price, D. H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx262 · Cited by 51

HIV-1 Tat: An update on transcriptional and non-transcriptional functions

Ali, A., Mishra, R., Kaur, H., & Banerjea, A. C. (2021) · Biochimie · doi:10.1016/j.biochi.2021.07.001 · Cited by 50

CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90

Breuer, D., Kotelkin, A., Ammosova, T., Kumari, N., Ivanov, A. I., Ilatovskiy, A. V., Beullens, M., Roane, P. R., Bollen, M., Petukhov, M., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-94 · Cited by 50

Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity

Xu, J., Li, H., Wang, X., Huang, J., Li, S., Liu, C., Dong, R., Zhu, G., Duan, C., Jiang, F., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112424 · Cited by 50

An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb

Kobbi, L., Demey, E., Brayé, F., Proux, F., Kolesnikova, O., Vinh, J., Poterszman, A., & Bensaude, O. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612331113 · Cited by 47

Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR

Zeiger, M., Stark, S., Kalden, E., Ackermann, B., Ferner, J., Scheffer, U., Shoja-Bazargani, F., Erdel, V., Schwalbe, H., & Göbel, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.004 · Cited by 45

Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery

Chavali, S. S., Bonn, R. B., & Wedekind, J. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006860 · Cited by 47

Effect of Mimetic CDK9 Inhibitors on HIV-1-Activated Transcription

Duyne, R. V., Guendel, I., Jaworski, E. M., Sampey, G. C., Klase, Z. A., Chen, H., Zeng, C., Kovalskyy, D., el Kouni, M. H., Lepene, B. S., et al. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.12.005 · Cited by 44

Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9

Phillipson, L. J., Segal, D., Nero, T. L., Parker, M. W., Wan, S. S., de Silva, M., Guthridge, M. A., Wei, A. H., & Burns, C. J. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.08.035 · Cited by 43

HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies

Asamitsu, K., Fujinaga, K., & Okamoto, T. (2018) · Molecules · doi:10.3390/molecules23040933 · Cited by 45

The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro–Cortistatin A

Li, C., Mori, L., & Valente, S. T. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa681 · Cited by 42

Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription

Mousseau, G., & Valente, S. T. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170622104355 · Cited by 41

The Drosophila 7SK snRNP and the essential role of dHEXIM in development

Nguyen, D. K., Krueger, B. J., Sedore, S. C., Brogie, J. E., Rogers, J. T., Rajendra, T. K., Saunders, A., Matera, A. G., Lis, J. T., Uguen, P., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks191 · Cited by 41

Structural characterization of the cyclin-dependent protein kinase family

Endicott, J., & Noble, M. E. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130097 · Cited by 40

Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding

Dixon-Clarke, S. E., Elkins, J. M., Cheng, S.-W. G., Morin, G. B., & Bullock, A. N. (2015) · Scientific Reports · doi:10.1038/srep17122 · Cited by 38

Transcription elongation control by the 7SK snRNP complex: Releasing the pause

McNamara, R. P., Bacon, C. W., & D’Orso, I. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1181241 · Cited by 41

The CDK9 Tail Determines the Reaction Pathway of Positive Transcription Elongation Factor b

Baumli, S., Hole, A. J., Wang, L.-Z., Noble, M. E. M., & Endicott, J. (2012) · Structure · doi:10.1016/j.str.2012.08.011 · Cited by 38

Computer‐Aided Design, Synthesis and Validation of 2‐Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti‐HIV‐1 Tat‐Mediated Transcription Activity

Sancineto, L., Iraci, N., Massari, S., Attanasio, V., Corazza, G., Barreca, M. L., Sabatini, S., Manfroni, G., Avanzi, N. R., Cecchetti, V., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300287 · Cited by 37

Structural basis for ELL2 and AFF4 activation of HIV-1 proviral transcription

Qi, S., Li, Z., Schulze‐Gahmen, U., Stjepanović, G., Zhou, Q., & Hurley, J. H. (2017) · Nature Communications · doi:10.1038/ncomms14076 · Cited by 37

P-TEFb goes viral

Zaborowska, J., Isa, N. F., & Murphy, S. (2015) · Inside the Cell · doi:10.1002/icl3.1037 · Cited by 36

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation

Faust, T. B., Li, Y., Bacon, C. W., Jang, G. Μ., Weiss, A., Jayaraman, B., Newton, B. W., Krogan, N. J., D’Orso, I., & Frankel, A. D. (2018) · eLife · doi:10.7554/elife.31879 · Cited by 36

Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene

Alhakamy, N. A., Fahmy, U. A., & Ahmed, O. A. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226639 · Cited by 35

Varying Modulation of HIV-1 LTR Activity by BAF Complexes

Duyne, R. V., Guendel, I., Narayanan, A., Gregg, E. W., Shafagati, N., Tyagi, M., Easley, R., Klase, Z. A., Nekhai, S. A., Kehn‐Hall, K., et al. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.06.001 · Cited by 36

The role of HIV Tat protein in HIV-related cardiovascular diseases

Jiang, Y., Chai, L., Fasae, M. B., & Bai, Y. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1500-0 · Cited by 35

P‐TEFb goes viral

Zaborowska, J., Isa, N. F., & Murphy, S. (2016) · BioEssays · doi:10.1002/bies.201670912 · Cited by 34

Tat basic domain: A “Swiss army knife” of HIV‐1 Tat?

Kurnaeva, M. A., Sheval, E. V., Musinova, Y. R., & Vassetzky, Y. S. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2031 · Cited by 33

Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure

Jin, H., Li, D., Lin, M., Li, L., & Harrich, D. (2020) · Viruses · doi:10.3390/v12040415 · Cited by 33

The CD8 + T Cell Noncytotoxic Antiviral Responses

Morvan, M. G., Teque, F., Locher, C. P., & Levy, J. A. (2021) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00155-20 · Cited by 34

PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription

Faust, T. B., Li, Y., Jang, G. Μ., Johnson, J. R., Yang, S., Weiss, A., Krogan, N. J., & Frankel, A. D. (2017) · Scientific Reports · doi:10.1038/srep45394 · Cited by 34

Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions

Tiwari, S., Atluri, V. S. R., Yndart, A., Jayant, R. D., Kaushik, A. K., Geiger, J. D., & Nair, M. N. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00291 · Cited by 32

Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d -enantiomeric peptide

Jiang, N., Frenzel, D., Schartmann, E., van Groen, T., Kadish, I., Shah, N. J., Langen, K., Willbold, D., & Willuweit, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.07.002 · Cited by 32

HIV-1 Tat: Its Dependence on Host Factors is Crystal Clear

D’Orso, I., & Frankel, A. D. (2010) · Viruses · doi:10.3390/v2102226 · Cited by 19

Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4

Gu, J., Babayeva, N. D., Suwa, Y., Baranovskiy, A. G., Price, D. H., & Tahirov, T. H. (2014) · Cell Cycle · doi:10.4161/cc.28756 · Cited by 58

Tat-SF: A Cellular Factor for Regulation of Transcriptional Elongation by HIV Tat

Zhou, Q., & Luo, K. (1999) · Defense Technical Information Center (DTIC)

The Control of HIV Transcription: Keeping RNA Polymerase II on Track

Ott, M., Geyer, M., & Zhou, Q. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.11.002 · Cited by 284

Tat-SF: A Cellular Factor for Regulation of Transcriptional Elongatin by HIV Tat-

Zhou, Q., & Lou, K. (2000) · Defense Technical Information Center (DTIC) · doi:10.21236/ada391394